+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Pneumococcal Vaccine Market 2023-2027

  • PDF Icon

    Report

  • 155 Pages
  • September 2023
  • Region: Global
  • TechNavio
  • ID: 5880886
1h Free Analyst Time
Description Jump to:

Advancements in Vaccine Technologies is a Key Trend Gaining Market Momentum

1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The global pneumococcal vaccine market is forecasted to grow by USD 2.82 billion during 2022-2027, accelerating at a CAGR of 5.81% during the forecast period. The market is driven by expanding immunization programs by government in developing countries, increasing awareness regarding vaccination, and growing incidences of pneumococcal diseases.

This report on the pneumococcal vaccine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment.

The global pneumococcal vaccine market is segmented as below:

By Type

  • Pneumococcal conjugate vaccine
  • Pneumococcal polysaccharide vaccine

By Distribution Channel

  • Non-governmental organizations
  • Government authorities
  • Distribution partner companies

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the advancements in vaccine technologies as one of the prime reasons driving the pneumococcal vaccine market growth during the next few years. Also, emergence of novel pneumococcal vaccines and emergence of combination vaccines will lead to sizable demand in the market.

The report on the pneumococcal vaccine market covers the following areas:

  • Pneumococcal vaccine market sizing
  • Pneumococcal vaccine market forecast
  • Pneumococcal vaccine market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading pneumococcal vaccine market vendors that include Astellas Pharma Inc., CSL Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Inc., Biological E. Ltd., Inventprise Inc., Petrovax, Vaxcyte Inc., and Walvax Biotechnology Co. Ltd.. Also, the pneumococcal vaccine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Exhibit 07: Executive Summary - Chart on Incremental Growth
  • Exhibit 08: Executive Summary - Data Table on Incremental Growth
  • Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
  • Exhibit 10: Parent market
  • Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
  • Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
  • Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
  • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
  • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
  • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global pneumococcal vaccine market 2017 - 2021
  • Exhibit 18: Historic Market Size - Data Table on global pneumococcal vaccine market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
  • Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 Distribution Channel Segment Analysis 2017 - 2021
  • Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
  • Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
  • Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
  • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
  • Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
  • Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
  • Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
  • Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
  • Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
  • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type
6.1 Market segments
  • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
  • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
  • Exhibit 32: Chart on Comparison by Type
  • Exhibit 33: Data Table on Comparison by Type
6.3 Pneumococcal conjugate vaccine - Market size and forecast 2022-2027
  • Exhibit 34: Chart on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 35: Data Table on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 36: Chart on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibit 37: Data Table on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
6.4 Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027
  • Exhibit 38: Chart on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 39: Data Table on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
  • Exhibit 40: Chart on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
  • Exhibit 41: Data Table on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Type
  • Exhibit 42: Market opportunity by Type ($ million)
  • Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Distribution Channel
7.1 Market segments
  • Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
  • Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
7.2 Comparison by Distribution Channel
  • Exhibit 46: Chart on Comparison by Distribution Channel
  • Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Non-governmental organizations - Market size and forecast 2022-2027
  • Exhibit 48: Chart on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
  • Exhibit 49: Data Table on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
  • Exhibit 50: Chart on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
  • Exhibit 51: Data Table on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
7.4 Government authorities - Market size and forecast 2022-2027
  • Exhibit 52: Chart on Government authorities - Market size and forecast 2022-2027 ($ million)
  • Exhibit 53: Data Table on Government authorities - Market size and forecast 2022-2027 ($ million)
  • Exhibit 54: Chart on Government authorities - Year-over-year growth 2022-2027 (%)
  • Exhibit 55: Data Table on Government authorities - Year-over-year growth 2022-2027 (%)
7.5 Distribution partner companies - Market size and forecast 2022-2027
  • Exhibit 56: Chart on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 57: Data Table on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
  • Exhibit 58: Chart on Distribution partner companies - Year-over-year growth 2022-2027 (%)
  • Exhibit 59: Data Table on Distribution partner companies - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Distribution Channel
  • Exhibit 60: Market opportunity by Distribution Channel ($ million)
  • Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
8 Customer Landscape
8.1 Customer landscape overview
  • Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
  • Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
  • Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
  • Exhibit 65: Chart on Geographic comparison
  • Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
  • Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
  • Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
  • Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
  • Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
  • Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
  • Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
  • Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
  • Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
  • Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
  • Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
  • Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
  • Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
  • Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
  • Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
  • Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
  • Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
  • Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 UK - Market size and forecast 2022-2027
  • Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
  • Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
  • Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
  • Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
  • Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
  • Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 China - Market size and forecast 2022-2027
  • Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
  • Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
  • Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
  • Exhibit 103: Market opportunity By Geographical Landscape ($ million)
  • Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
  • Exhibit 105: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
  • Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
  • Exhibit 107: Overview on factors of disruption
11.4 Industry risks
  • Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
  • Exhibit 109: Vendors covered
12.2 Market positioning of vendors
  • Exhibit 110: Matrix on vendor position and classification
12.3 Astellas Pharma Inc.
  • Exhibit 111: Astellas Pharma Inc. - Overview
  • Exhibit 112: Astellas Pharma Inc. - Product / Service
  • Exhibit 113: Astellas Pharma Inc. - Key news
  • Exhibit 114: Astellas Pharma Inc. - Key offerings
12.4 Biological E. Ltd.
  • Exhibit 115: Biological E. Ltd. - Overview
  • Exhibit 116: Biological E. Ltd. - Product / Service
  • Exhibit 117: Biological E. Ltd. - Key offerings
12.5 CSL Ltd.
  • Exhibit 118: CSL Ltd. - Overview
  • Exhibit 119: CSL Ltd. - Business segments
  • Exhibit 120: CSL Ltd. - Key offerings
  • Exhibit 121: CSL Ltd. - Segment focus
12.6 GlaxoSmithKline Plc
  • Exhibit 122: GlaxoSmithKline Plc - Overview
  • Exhibit 123: GlaxoSmithKline Plc - Business segments
  • Exhibit 124: GlaxoSmithKline Plc - Key news
  • Exhibit 125: GlaxoSmithKline Plc - Key offerings
  • Exhibit 126: GlaxoSmithKline Plc - Segment focus
12.7 Merck and Co. Inc.
  • Exhibit 127: Merck and Co. Inc. - Overview
  • Exhibit 128: Merck and Co. Inc. - Business segments
  • Exhibit 129: Merck and Co. Inc. - Key news
  • Exhibit 130: Merck and Co. Inc. - Key offerings
  • Exhibit 131: Merck and Co. Inc. - Segment focus
12.8 Panacea Biotec Ltd.
  • Exhibit 132: Panacea Biotec Ltd. - Overview
  • Exhibit 133: Panacea Biotec Ltd. - Product / Service
  • Exhibit 134: Panacea Biotec Ltd. - Key offerings
12.9 Petrovax
  • Exhibit 135: Petrovax - Overview
  • Exhibit 136: Petrovax - Product / Service
  • Exhibit 137: Petrovax - Key offerings
12.10 Pfizer Inc.
  • Exhibit 138: Pfizer Inc. - Overview
  • Exhibit 139: Pfizer Inc. - Product / Service
  • Exhibit 140: Pfizer Inc. - Key news
  • Exhibit 141: Pfizer Inc. - Key offerings
12.11 Sanofi
  • Exhibit 142: Sanofi - Overview
  • Exhibit 143: Sanofi - Business segments
  • Exhibit 144: Sanofi - Key news
  • Exhibit 145: Sanofi - Key offerings
  • Exhibit 146: Sanofi - Segment focus
12.12 Serum Institute of India Pvt. Ltd.
  • Exhibit 147: Serum Institute of India Pvt. Ltd. - Overview
  • Exhibit 148: Serum Institute of India Pvt. Ltd. - Product / Service
  • Exhibit 149: Serum Institute of India Pvt. Ltd. - Key offerings
12.13 Shenzhen Kangtai Biological Products Co. Ltd.
  • Exhibit 150: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
  • Exhibit 151: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
  • Exhibit 152: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
12.14 Sinovac Biotech Ltd.
  • Exhibit 153: Sinovac Biotech Ltd. - Overview
  • Exhibit 154: Sinovac Biotech Ltd. - Product / Service
  • Exhibit 155: Sinovac Biotech Ltd. - Key offerings
12.15 SK Inc.
  • Exhibit 156: SK Inc. - Overview
  • Exhibit 157: SK Inc. - Product / Service
  • Exhibit 158: SK Inc. - Key offerings
12.16 Vaxcyte Inc.
  • Exhibit 159: Vaxcyte Inc. - Overview
  • Exhibit 160: Vaxcyte Inc. - Product / Service
  • Exhibit 161: Vaxcyte Inc. - Key offerings
12.17 Walvax Biotechnology Co. Ltd.
  • Exhibit 162: Walvax Biotechnology Co. Ltd. - Overview
  • Exhibit 163: Walvax Biotechnology Co. Ltd. - Product / Service
  • Exhibit 164: Walvax Biotechnology Co. Ltd. - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
  • Exhibit 165: Inclusions checklist
  • Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
  • Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
  • Exhibit 168: Research methodology
  • Exhibit 169: Validation techniques employed for market sizing
  • Exhibit 170: Information sources
13.5 List of abbreviations
  • Exhibit 171: List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 5: Executive Summary - Chart on Market Segmentation by Type
Exhibit 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 7: Executive Summary - Chart on Incremental Growth
Exhibit 8: Executive Summary - Data Table on Incremental Growth
Exhibit 9: Executive Summary - Chart on Vendor Market Positioning
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
Exhibit 12: Offerings of vendors included in the market definition
Exhibit 13: Market segments
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 18: Historic Market Size - Data Table on global pneumococcal vaccine market 2017 - 2021 ($ million)
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibit 20: Historic Market Size - Distribution Channel Segment 2017 - 2021 ($ million)
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
Exhibit 34: Chart on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Pneumococcal conjugate vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Pneumococcal conjugate vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 38: Chart on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Pneumococcal polysaccharide vaccine - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Pneumococcal polysaccharide vaccine - Year-over-year growth 2022-2027 (%)
Exhibit 42: Market opportunity by Type ($ million)
Exhibit 43: Data Table on Market opportunity by Type ($ million)
Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
Exhibit 48: Chart on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Non-governmental organizations - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Non-governmental organizations - Year-over-year growth 2022-2027 (%)
Exhibit 52: Chart on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Government authorities - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Government authorities - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Government authorities - Year-over-year growth 2022-2027 (%)
Exhibit 56: Chart on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Distribution partner companies - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Distribution partner companies - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Distribution partner companies - Year-over-year growth 2022-2027 (%)
Exhibit 60: Market opportunity by Distribution Channel ($ million)
Exhibit 61: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 63: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
Exhibit 67: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibit 71: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 75: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 83: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibit 87: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibit 95: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 99: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibit 103: Market opportunity By Geographical Landscape ($ million)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibit 105: Impact of drivers and challenges in 2022 and 2027
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
Exhibit 107: Overview on factors of disruption
Exhibit 108: Impact of key risks on business
Exhibit 109: Vendors covered
Exhibit 110: Matrix on vendor position and classification
Exhibit 111: Astellas Pharma Inc. - Overview
Exhibit 112: Astellas Pharma Inc. - Product / Service
Exhibit 113: Astellas Pharma Inc. - Key news
Exhibit 114: Astellas Pharma Inc. - Key offerings
Exhibit 115: Biological E. Ltd. - Overview
Exhibit 116: Biological E. Ltd. - Product / Service
Exhibit 117: Biological E. Ltd. - Key offerings
Exhibit 118: CSL Ltd. - Overview
Exhibit 119: CSL Ltd. - Business segments
Exhibit 120: CSL Ltd. - Key offerings
Exhibit 121: CSL Ltd. - Segment focus
Exhibit 122: GlaxoSmithKline Plc - Overview
Exhibit 123: GlaxoSmithKline Plc - Business segments
Exhibit 124: GlaxoSmithKline Plc - Key news
Exhibit 125: GlaxoSmithKline Plc - Key offerings
Exhibit 126: GlaxoSmithKline Plc - Segment focus
Exhibit 127: Merck and Co. Inc. - Overview
Exhibit 128: Merck and Co. Inc. - Business segments
Exhibit 129: Merck and Co. Inc. - Key news
Exhibit 130: Merck and Co. Inc. - Key offerings
Exhibit 131: Merck and Co. Inc. - Segment focus
Exhibit 132: Panacea Biotec Ltd. - Overview
Exhibit 133: Panacea Biotec Ltd. - Product / Service
Exhibit 134: Panacea Biotec Ltd. - Key offerings
Exhibit 135: Petrovax - Overview
Exhibit 136: Petrovax - Product / Service
Exhibit 137: Petrovax - Key offerings
Exhibit 138: Pfizer Inc. - Overview
Exhibit 139: Pfizer Inc. - Product / Service
Exhibit 140: Pfizer Inc. - Key news
Exhibit 141: Pfizer Inc. - Key offerings
Exhibit 142: Sanofi - Overview
Exhibit 143: Sanofi - Business segments
Exhibit 144: Sanofi - Key news
Exhibit 145: Sanofi - Key offerings
Exhibit 146: Sanofi - Segment focus
Exhibit 147: Serum Institute of India Pvt. Ltd. - Overview
Exhibit 148: Serum Institute of India Pvt. Ltd. - Product / Service
Exhibit 149: Serum Institute of India Pvt. Ltd. - Key offerings
Exhibit 150: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
Exhibit 151: Shenzhen Kangtai Biological Products Co. Ltd. - Product / Service
Exhibit 152: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
Exhibit 153: Sinovac Biotech Ltd. - Overview
Exhibit 154: Sinovac Biotech Ltd. - Product / Service
Exhibit 155: Sinovac Biotech Ltd. - Key offerings
Exhibit 156: SK Inc. - Overview
Exhibit 157: SK Inc. - Product / Service
Exhibit 158: SK Inc. - Key offerings
Exhibit 159: Vaxcyte Inc. - Overview
Exhibit 160: Vaxcyte Inc. - Product / Service
Exhibit 161: Vaxcyte Inc. - Key offerings
Exhibit 162: Walvax Biotechnology Co. Ltd. - Overview
Exhibit 163: Walvax Biotechnology Co. Ltd. - Product / Service
Exhibit 164: Walvax Biotechnology Co. Ltd. - Key offerings
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
Exhibit 167: Currency conversion rates for US$
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
Exhibit 171: List of abbreviations

Executive Summary

The research team recognizes the following companies as the key players in the global pneumococcal vaccine market: Astellas Pharma Inc., CSL Ltd., GlaxoSmithKline Plc, Merck and Co. Inc., Panacea Biotec Ltd., Pfizer Inc., Sanofi, Serum Institute of India Pvt. Ltd., Shenzhen Kangtai Biological Products Co. Ltd., Sinovac Biotech Ltd., SK Inc., Biological E. Ltd., Inventprise Inc., Petrovax, Vaxcyte Inc., and Walvax Biotechnology Co. Ltd.

One of the report's analysts commented on the report, saying: 'The latest trend gaining momentum in the market is advancements in vaccine technologies.'

According to the report, one of the major drivers for this market is the expanding immunization programs by government in developing countries.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Astellas Pharma Inc.
  • CSL Ltd.
  • GlaxoSmithKline PLC
  • Merck and Co. Inc.
  • Panacea Biotec Ltd.
  • Pfizer Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.
  • Sinovac Biotech Ltd.
  • SK Inc.
  • Biological E. Ltd.
  • Inventprise Inc.
  • Petrovax
  • Vaxcyte Inc.
  • Walvax Biotechnology Co. Ltd.

Related Topics

Related Reports

Pneumococcal Vaccine Global Market Report 2024 - Product Image

Pneumococcal Vaccine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Global Pneumococcal Vaccine Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Pneumococcal Vaccine Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 213 Pages
  • Global
From
Pneumococcal Vaccine Market Report by Vaccine Type, Product Type, Distribution Channel, End User, and Region 2023-2028 - Product Image

Pneumococcal Vaccine Market Report by Vaccine Type, Product Type, Distribution Channel, End User, and Region 2023-2028

  • Report
  • 146 Pages
  • Global
From
Pneumococcal Vaccines Market : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030 - Product Image

Pneumococcal Vaccines Market : Global Industry Analysis, Trends, Market Size, and Forecasts up to 2030

  • Report
  • 180 Pages
  • Global
From
Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Pneumococcal Vaccines - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.